Harbor Capital Advisors, Inc. Rocket Pharmaceuticals, Inc. Transaction History
Harbor Capital Advisors, Inc.
- $2.3 Billion
- Q3 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 168,506 shares of RCKT stock, worth $2.03 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
168,506
Previous 97,134
73.48%
Holding current value
$2.03 Million
Previous $2.09 Million
48.83%
% of portfolio
0.14%
Previous 0.16%
Shares
12 transactions
Others Institutions Holding RCKT
# of Institutions
209Shares Held
93.2MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$213 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$135 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$74.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$66.6 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$54.1 Million0.39% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $910M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...